These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 26765465)
1. Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer. Xu J; Ye Y; Zhang H; Szmitkowski M; Mäkinen MJ; Li P; Xia D; Yang J; Wu Y; Wu H Medicine (Baltimore); 2016 Jan; 95(2):e2502. PubMed ID: 26765465 [TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer. Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysis. Jin WJ; Xu JM; Xu WL; Gu DH; Li PW World J Gastroenterol; 2014 Nov; 20(43):16334-42. PubMed ID: 25473192 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis. Zhang H; Li P; Ju H; Pesta M; Kulda V; Jin W; Cai M; Liu C; Wu H; Xu J; Ye Y; Zhang G; Xu E; Cai J; Lai M; Xia D; Yang J; Wu Y Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2783-92. PubMed ID: 25178983 [TBL] [Abstract][Full Text] [Related]
5. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer. Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598 [TBL] [Abstract][Full Text] [Related]
6. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. Tan Y; Wu H Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243 [TBL] [Abstract][Full Text] [Related]
7. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma. Gong W; Tian M; Qiu H; Yang Z Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of miR-106a in colorectal cancer. Hao H; Liu L; Zhang D; Wang C; Xia G; Zhong F; Hu X Oncotarget; 2017 Jan; 8(3):5038-5047. PubMed ID: 27926519 [TBL] [Abstract][Full Text] [Related]
9. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis. Yu Z; Chen Z; Wu J; Li Z; Wu Y PLoS One; 2017; 12(11):e0188139. PubMed ID: 29141049 [TBL] [Abstract][Full Text] [Related]
11. Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Tan D; Fu Y; Su Q; Wang H Medicine (Baltimore); 2016 Jun; 95(24):e3837. PubMed ID: 27310960 [TBL] [Abstract][Full Text] [Related]
12. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis. Xu F; Xu L; Wang M; An G; Feng G Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis. Zhang Y; Yang X Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis. Xia W; Chen W; Zhang Z; Wu D; Wu P; Chen Z; Li C; Huang J PLoS One; 2015; 10(4):e0123484. PubMed ID: 25856316 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of LGR5 in colorectal cancer: a meta-analysis. Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390 [TBL] [Abstract][Full Text] [Related]
16. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis. Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958 [TBL] [Abstract][Full Text] [Related]
17. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. Lv ZC; Fan YS; Chen HB; Zhao DW Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214 [TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinase-9 level as a biomarker for colorectal cancer: a diagnostic meta-analysis. Liang S; Chang L Biomark Med; 2018 Apr; 12(4):393-402. PubMed ID: 29575908 [TBL] [Abstract][Full Text] [Related]
19. Combined detection of preoperative neutrophil to lymphocyte ratio and interleukin-6 as an independent prognostic factor for patients with non-metastatic colorectal cancer. Yang Z; Li Y; Zhang K; Deng X; Yang S; Wang Z J Gastrointest Oncol; 2021 Dec; 12(6):2838-2845. PubMed ID: 35070411 [TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients. Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]